ABM Industries is a leading technology company focused on innovation and creating and monetizing its…
Coloplast Patent Portfolio – Exemplary Landscape Overview
Coloplast is a leading technology company focused on innovation and creating and monetizing its Intellectual Property across jurisdictions. This exemplary study/report presents a high-level brief analysis of the Patent Portfolio of the Corporate, and various attributes/parameters on which the said entities Patent Portfolio is being represented.
Coloplast along with its key subsidiaries has a total of around 6761 patents/applications globally as of the date of the instant publication, out of which 2170 patents have been issued. Of these 6761 patents/applications, more than 39.82% patents/applications are active. United States is where Coloplast has filed the maximum number of patents, followed by European Patent Office.
Most of the patents of the Coloplast are in the classification of A61F and A61M, which indicates the core areas of technology focus of the company.


The below graphical representation indicates yearly filing trends of the Coloplast, which shows that the number of applications peaked in 2011 with 2023-2024 filings potentially still being recorded, indicating that the trend could rise further.
How many Coloplast Portfolio patents are Alive/Dead?
Countries in which Coloplast Filed Patents
10 Best Coloplast Portfolio Patents
The patent US8690893 is the most cited in the portfolio, with 812 citations to date.
Coloplast Portfolio Top 10 Inventors
Us is the top inventor with 1437 filings.
Patent Family with Most Filings
The patent family 718438 has the highest number of filings worldwide, with 139 unique family members.







